Balance Sheet Components

6 Months Ended

Jun. 30, 2021

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components

Balance Sheet Components

Goodwill

The changes in the carrying amounts of goodwill were as follows (in thousands of dollars):

	Amounts
Balance as of December 31, 2020	$	2,725
Goodwill Acquired - Decipher Biosciences	469,039
Balance as of June 30, 2021	$	471,764

Intangible Assets, Net

Intangible assets include finite-lived product technology, customer relationships, licenses and trade names and indefinite-lived in-process research and development. Intangible assets consisted of the following (in thousands of dollars):

	June 30, 2021						December 31, 2020						Weighted Average Amortization Period (Years)
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Percepta product technology	$	16,000	$	(6,667)	$	9,333	$	16,000	$	(6,133)	$	9,867	15
Prosigna product technology	4,120		(435)		3,685		4,120		(298)		3,822		15
Prosigna customer relationships	2,430		(770)		1,660		2,430		(526)		1,904		5
nCounter Dx license	46,880		(4,947)		41,933		46,880		(3,386)		43,494		15
LymphMark product technology	990		(224)		766		990		(153)		837		7
Decipher product technology	90,000		(2,734)		87,266		—		—		—		10
Decipher trade names	4,000		(243)		3,757		—		—		—		5
Total finite-lived intangibles	164,420		(16,020)		148,400		70,420		(10,496)		59,924		11.7
In-process research and development	7,300		—		7,300		—		—		—
Total intangible assets	$	171,720	$	(16,020)	$	155,700	$	70,420	$	(10,496)	$	59,924

Amortization of the finite-lived intangible assets is recognized on a straight-line basis. Amortization expense of $3.7 million and $1.3 million was recognized for the three months ended June 30, 2021 and 2020, respectively. Amortization expense of $5.5 million and $2.5 million was recognized for the six months ended June 30, 2021 and 2020, respectively.

The estimated future aggregate amortization expense as of June 30, 2021 is as follows (in thousands of dollars):

Year Ending December 31,	Amounts
2021 remainder of year	$	7,448
2022	14,894
2023	14,894
2024	14,854
2025	14,408
Thereafter	81,902
Total	$	148,400

 

Accrued Liabilities

Accrued liabilities consisted of the following (in thousands of dollars):

	June 30, 2021		December 31, 2020
Accrued compensation expenses	$	12,600	$	9,201
Accrued other	8,156		2,504
Total accrued liabilities	$	20,756	$	11,705